botmzup
16 Feb 2017
Re: Disorder is fake You`re on the GRPH board now! I think you`re getting a bit confused and should try to focus on one thing at a time, like who to ramp nextI do not intend to carry this on on this board because its not fair to people who tune in looking to chat about GRPH.You`ve already used and abused this discussion by coming on here with your extended ramblings and over ramping of a completely different company. I`m not the one who gatecrashed a totally unrelated site with a rambling ramp, you were. Liberty taking ***tIf you have any more to say, say it on the SNG board and bore them to death.You`re a self important ego maniac who thinks that what you have to say is more important than anyone else, and nobody understands like you do.So now `do one`, go and comb your hair and kiss your mirror!
Disorder
16 Feb 2017
Re: Disorder is fake Botmzup.You posted and I quote:15:59 Re: Interest. BotmzupSNG.LMe me me me me!Ooh I detect she`s got her knickers in a twist, splendid.Thanks for letting the world know how tremendous you are, you should run for `President and legend in your own mind`!You got me curious too, about my `one` wrong site ramp, and even though I still can`t find it, or the date of it, I`m thinking it must have been well back in 2015 when the price was being held back with the overhang. So that would have made my `one` offsite ramp share price more like 6-7p.So the profit now moves up to ~200%!!Wow, I didn`t realise I was so good!Kisses!::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::You are How Old?In charge of your own finances?OK. I guess it takes all sorts. And I wont prejudge you based on your ramblings but assume maybe you have gained access to your fathers account.But do be aware that your parents will be able to see the posting history when they log back on.Reading back on your posts you state that you trade quickly, dont become attached to a stock and clear off as soon as your target profit is achieved. (The target profit you aspire to a few times is enough for a cheap meal out)Thus to proclaim your magnificence and suggest 200% profits are what you have achieved is somewhat misleading, as your style suggests you encourage others to buy based on suggestions like "No company news must mean the BOD have received an offer", and get into this one quick as I feel good things are about to happen, when your intention is to actually leave as soon as your rather low profit points are met.Can we take this to another forum, as it really is very selfish of us both to clutter what was otherwise a decent bb.I will meet you on GRPH instead.
botmzup
16 Feb 2017
Re: Disorder is fake yeah yeah yeah, all practiced bs comebacks.I`ve done this I`ve done that, I`ve got 100k in here and 250k in there bla bla bla!Go back over to your relevant boards and carry on your gobbing off over there, like SNG that you only started posting on two weeks ago once it had already started moving.You`re just full of ramping bs, and you might fool some `late newcomers` but you ain`t fooling me.I do well enough without shysters like you thanks.
Disorder
16 Feb 2017
Re: Disorder is fake Brilliant....You couldnt make it up...I am a fake.I push SNGI push VOGI dont tend to push GKP because i am actually down about 80%on that, holding circa £287k shares (cost to me)SNG... hmmmmmm. I pop into the Style on an occaisional Friday afternoon.You know the style... on the corner of burgess road on the uni campus.If you had something to say abot SNG that didnt make it the screaming buy it is, then i would maybe give your warning some credibility.Maybe Richard Griffiths who recently increased his stake in SNG to 11% was taken in by me? LolMaybe the buy recs for VOG have also been in vain, and amongst other things the analysts putting a £1.70 target were also taken in by me?Then my latest... "MWG" MODERN WATER...... i promote that from this week as a very strong buy.Guess what? I am driving up to Guildford at 10amI take my investing very seriously.Maybe you could do the same instead of looking for conspiracy theories.Maybe you could even buy some MWG??? But then again, maybe not. 
susanne9
15 Feb 2017
disorder He/She has been doing the same on VOG
botmzup
15 Feb 2017
Disorder is fake Having re read my last post and looked at the SNG discussion its glaringly obvious that this Disorder character is an extreme ramper and is only ramping SNG while it bounces from 12p to its current 30p. As soon as it turns back down he will be one of the profit takers and then long gone.Seen it too many times, be aware...be very aware!!!ps Disorder, also see my previous post on here. Bye
botmzup
15 Feb 2017
Re: Potential You`re out of order Disorder.You come on here spouting about how risky GRPH are for about 2 sentences with no real research to back it up and then go on some rambling blog about another company which isn`t even in the same sector. You`re on the wrong discussion!A company which is also risky, as all Pharm and Biotech companies are until they have a successful product.A company whose share price was the same price two years ago as it is today, and that's after falling back to its all time low of ~12p...and, it was also at the same price 5 years ago!!It`s bounced off its all time low which is largely a technical bounce which any chartist would tell you has a high probability of happening, its just a traders target price of long term support.So its continued up from 12p to 30p, on no news, and without any new news I can see the profit takers selling in to this as soon as it stops rising...and its in overbought territory now!Technically SNG are still in a long term down trend and this recent rise looks to just be a retrace within that trend, a traders dream ticket.The last RNS update was in Oct`16 which was to announce that......"AstraZeneca has decided to stop the Phase IIa trial for AZD9412 based on an interim analysis, where an overall very low number of reported severe exacerbations could make primary endpoint conclusions difficult. "The interim analysis confirmed the positive safety and tolerability profile seen in previous trials, and inhaled IFN-b remains an interesting treatment opportunity for patients with respiratory disease. AstraZeneca will now review the data and study design before deciding on the best way forward for the programme."You just happen to have fallen in love with this company and have a cloudy red tinted opinion of them, whatever the sp has done (or not done) and whatever the company`s failings are.Please direct your fanzine to the appropriate discussion board in future and keep this discussion on Graphene Nanochem.
Disorder
13 Feb 2017
Re: Potential Personally i think you have made the right decision.SNG is very very exciting.Ignore the fact that according to brokers it has a target of £1.37Its in an area where MA is rife.Some chartists are saying once through 25p its blue skies to 40p.Lets see.All the best.
alltold9
13 Feb 2017
Re: Potential Taken your advise 'disorder' sold out while I could this illiquid stock; and took 10% loss on the chin. Bought SOLO as like the current story.Still considering you recommendation!
alltold9
11 Feb 2017
Re: Potential Again great research 'disorder' but will see how GRPH pans out, as I genuinely think there us plenty of life left in this old dog yet. Time will tell. No pain no gain. Have a good weekend.
Disorder
11 Feb 2017
Re: Potential Be very very very extremely careful here Alltold.I guess you are relying on the liquidity to create a spike?I have no doubt it can be achieved, but the odds are actually looking in favour of it going bust.If you are putting real money into this then I would personally only use "Gambling" money.If it pays off then good, but if you lose and are left holding when a suspension notice comes, then accept it as that... One lost..Far far far to risky for me... I keep my gambling to the horses on the weekend if I have time to review them.But stocks, thats a different story: I like to win.Unfortunately it doesnt always work that way, but with masses of research, and in fact living right on the doorstep of this next one I would much rather put my money into SYNAIRGEN (SNG)Richard Griffiths has been recently acquiring more, and with a conservative sp of £1.37 placed on it, it is certainly capapble of multibagging.I hold and have done for an age.I differ slightly I think from your investment rhetoric in that I do top slice, but I rarely sell out. Thus I have many holdings, some worth not a lot, some worth tens of thousands and many of them effectively free.For instance, when SNG reaches 60p I will top slice 50% of them.Try it... SNG and stick with it until your stake trebles..If the market worked as perfectly as its more rabid advocates insist, we wouldn’t have attractive anomalies such as Synairgen plc (LON:SNG).Its shares are trading at a fraction of what would be considered fair market price - particularly for a company sitting on a potential blockbuster drug.The respiratory specialist has also succeeded where many of its peers have failed in convincing one of the giants of the pharma world to fund the ongoing development of its lead product.The deal is worth just shy of quarter of a billion dollars.So why, you wonder, is the stock changing hands for 24.5p, giving Synairgen a market worth of just £22.5mln?That’s a complicated question – and a problem linked more to the liquidity of the shares than the company’s fundamentals.Small-cap specialist finnCap recently looked at Synairgen and came up with a valuation based on a discounted cash flow model of 137p.Not quite a ten bagger, but getting there.Anyway, parking the hyperbole for a moment it is worth looking at just whether the figures stack up.The company’s flagship product is AZD9412 (inhaled interferon beta), a treatment for patients with severe asthma, which Synairgen successfully nurtured through phase IIa trials before handing it over to AstraZeneca (AZ).In all, that deal is worth £158mln (US$225mln) in staged payments plus royalties.Currently AZ is repeating the phase IIa trial to see if it gets the same results as Synairgen, in the difficult-to-treat group of sufferers.There are reasons why, even at this early-to-intermediate stage of clinical trial process, AZD9412 is less risky than some other compounds negotiating the same route.It is repurposed interferon beta taken by multiple-sclerosis sufferers by injection, so the safety profile in blood is already well known.Synairgen’s inhaled version of the drug has been well tolerated by asthmatic patients when given by the inhaled route in Synairgen’s clinical trials – in other words it seems unlikely that this drug will fall over in development because of some as yet unknown safety concern. “Already lots of reasons why the drug can fail are off the table,” chief executive Richard Marsden told Proactive Investors. “The thing we are focused on is the results of the next trial”The read-out from the AZ clinical trial is expected sometime in the first half of next year.If positive the results of this study will provide a major catalyst for the currently lacklustre share price, which has traced its way down from 40p.The next staged payment from AZ, an estimated £7mln (US$10mln), will come once the phase IIb study gets un
alltold9
11 Feb 2017
Re: Potential Agree high risk, but with that high gain! My belief is their problems are behind them and a bright future lies ahead. Good luck whatever you choose.
Tom WM
11 Feb 2017
Re: Potential It would seem that you are unaware of the activities of Darwin. When you say DYOR this is a major factor.Having said that I did buy a small handful yesterday. But it's just a punt against them going bust.
alltold9
10 Feb 2017
Re: Potential Unbelievably short term target sp 100p+.dyor it's amazing. Next week will be epic!
alltold9
10 Feb 2017
Re: Potential Agree, I believe we will be hearing positive news on new ventures very soon, on this oversold stock. Hold on tight.
